[2] Ensuring adequate nutrition whilst using weight loss medications is essential for maintaining reproductive health alongside achieving weight management goals
The post says severe or worsening constipation, marked by abdominal pain, no bowel movement for three or more days, or an inability to manage it with self-care, warrants immediate provider evaluation
GPx activity varies by sample type and substrate, with the highest activity in erythrocytes, followed by liver, kidney, and serum
Table of Contents Who Cannot Take Weight Loss Injections Medical Conditions That Prevent Use of Weight Loss Injections Medications That Interact With Weight Loss Injections Pregnancy, Breastfeeding and Weight Loss Injections Age Restrictions and Safety Considerations When to Speak to Your GP About Weight Loss Injections Scientific References Frequently Asked Questions Who Cannot Take Weight Loss Injections Weight loss injections, primarily glucagon-like peptide-1 (GLP-1) receptor agonists such as semaglutide (Wegovy) and liraglutide (Saxenda), have become increasingly prescribed for weight management in the UK
Lee Y, Li W, Tang J, Schwendeman SP, Prausnitz MR
